- Home
- LNTH vs HAFN Comparison
LNTH vs HAFN Comparison
Compare LNTH & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- HAFN
- Stock Information
- Founded
- LNTH 1956
- HAFN 2012
- Country
- LNTH United States
- HAFN Singapore
- Employees
- LNTH N/A
- HAFN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HAFN
- Sector
- LNTH Health Care
- HAFN
- Exchange
- LNTH Nasdaq
- HAFN Nasdaq
- Market Cap
- LNTH 3.8B
- HAFN 3.3B
- IPO Year
- LNTH 2015
- HAFN N/A
- Fundamental
- Price
- LNTH $58.45
- HAFN $5.96
- Analyst Decision
- LNTH Buy
- HAFN Strong Buy
- Analyst Count
- LNTH 6
- HAFN 1
- Target Price
- LNTH $74.17
- HAFN $6.50
- AVG Volume (30 Days)
- LNTH 1.3M
- HAFN 1.2M
- Earning Date
- LNTH 11-06-2025
- HAFN 12-01-2025
- Dividend Yield
- LNTH N/A
- HAFN 10.59%
- EPS Growth
- LNTH N/A
- HAFN N/A
- EPS
- LNTH 2.39
- HAFN 0.84
- Revenue
- LNTH $1,525,933,000.00
- HAFN $2,354,657,000.00
- Revenue This Year
- LNTH N/A
- HAFN N/A
- Revenue Next Year
- LNTH $1.98
- HAFN N/A
- P/E Ratio
- LNTH $24.55
- HAFN $6.85
- Revenue Growth
- LNTH 1.95
- HAFN N/A
- 52 Week Low
- LNTH $47.25
- HAFN $3.61
- 52 Week High
- LNTH $111.29
- HAFN $6.64
- Technical
- Relative Strength Index (RSI)
- LNTH 61.44
- HAFN 39.54
- Support Level
- LNTH $51.84
- HAFN $5.88
- Resistance Level
- LNTH $57.35
- HAFN $6.54
- Average True Range (ATR)
- LNTH 2.31
- HAFN 0.15
- MACD
- LNTH 0.60
- HAFN -0.06
- Stochastic Oscillator
- LNTH 93.11
- HAFN 9.21
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.